AVLN - Company ID 0001540171
The table below shows Avalyn Pharma Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | -$29.89M | -$19.27M |
| Capital expenditure | $318.00K | $8.00K |
| Investing cash flow | $55.02M | $24.12M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $14.86M | $0.00 |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.